Key result
DHA-glycine shortens action potential duration by ~33% in human iPSC-derived cardiomyocytes.
Why the study?
Mutations in cardiac voltage-gated ion channels can cause LQTS, and PUFAs have emerged as potential therapeutics because they modulate voltage-gated ion channels.
PUFA analogues demonstrate differential and targetable modulatory effects on cardiac ion channels, highlighting a potential mechanism to therapeutically target specific forms of Long QT Syndrome.
Answers are grounded in this paper and cite their sources.
Should not yet alter LQTS management; hypothesis-generating for PUFA analogues targeting cardiac ion channels.
The cardiac ventricular action potential depends on several voltage-gated ion channels, including NaV, CaV, and KV channels. Mutations in these channels can cause Long QT Syndrome (LQTS) which increases the risk for ventricular fibrillation and sudden cardiac death. Polyunsaturated fatty acids (PUFAs) have emerged as potential therapeutics for LQTS because they are modulators of voltage-gated ion channels. Here we demonstrate that PUFA analogues vary in their selectivity for human voltage-gated ion channels involved in the ventricular action potential. The effects of specific PUFA analogues range from selective for a specific ion channel to broadly modulating cardiac ion channels from all three families (NaV, CaV, and KV). In addition, a PUFA analogue selective for the cardiac IKs channel (Kv7.1/KCNE1) is effective in shortening the cardiac action potential in human-induced pluripotent stem cell-derived cardiomyocytes. Our data suggest that PUFA analogues could potentially be developed as therapeutics for LQTS and cardiac arrhythmia.
No takes yet. Share an insight, caveat, or question.
Bohannon et al. (2020) studied Long QT Syndrome (LQTS) and cardiac arrhythmia. Polyunsaturated fatty acid (PUFA) analogues (e.g., DHA-glycine) vs. Control (0 μM) was evaluated on Corrected action potential duration (APD90c) (p=<0.05). The PUFA analogue DHA-glycine significantly shortened the corrected action potential duration in human-induced pluripotent stem cell-derived cardiomyocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: